角膜胶原交联术治疗进展期圆锥角膜的中期效果及硬性透气性角膜接触镜适配参数变化
前瞻性队列研究纳入41例(53只眼)进展期圆锥角膜患者,按角膜最薄点厚度分为去上皮CXL组(33只眼)和经上皮CXL组(20只眼),随访12个月。术后6周角膜曲率略变凸后逐渐恢复变平,经上皮组Kmax下降更早且更明显;术后RGPCL基弧均减小,环曲面边翘设计需求增加,两组抬边翘设计变化不同,术后1年内RGPCL仍可良好配适。
要点
- CXL术后6周Kf、Ks、Kmax均增加(P均<0.05),随后逐渐恢复并变平。
- 经上皮组Kmax在术后3、6、12个月均显著下降,降幅大于去上皮组。
- 术后RGPCL基弧减小(去上皮组0.07 mm,经上皮组0.13 mm),环曲面边翘设计需求增加。
核心结论
- 圆锥角膜患眼行CXL术后6周角膜略变凸后逐渐恢复并变平,经上皮术式效果更好。
- 术后6周配适RGPCL的基弧较术前变陡,边翘环曲面设计需求增加,但抬边翘设计两种术式变化不同。
- RGPCL于术后1年仍可良好配适。
研究设计与样本
- 前瞻性队列研究,纳入2018年5至12月于山东第一医科大学附属青岛眼科医院门诊接受快速CXL的进展期圆锥角膜患者41例(53只眼),男性31例、女性10例,年龄(20.46±4.15)岁。
- 根据角膜最薄点厚度是否≥450 μm分为去上皮组(33只眼)和经上皮组(20只眼),分别采用去上皮术式和经上皮术式行CXL。
- 术前及术后6周适配Rose K RGPCL并追踪配适情况至术后12个月;术前和术后6周检查最佳矫正视力和角膜最薄点厚度,术前、术后6周和3、6、12个月行角膜地形图检查获取Kf、Ks及Kmax。
- 采用t检验对数据进行统计学分析。
主要发现
- 术后6周时两组框架镜矫正视力、屈光度数及角膜最薄点厚度较术前无改变,但Kf、Ks及Kmax均增加(P均<0.05)。
- 去上皮组术前及术后3、6、12个月Kmax分别为(55.46±6.02)、(55.17±5.83)、(55.14±6.15)、(54.57±6.08)D,术后12个月下降(0.89±1.45)D(t=2.25,P=0.001)。
- 经上皮组术前及术后3、6、12个月Kmax分别为(59.43±8.98)、(57.97±8.79)、(58.19±8.37)、(56.94±7.19)D,术后3、6及12个月分别下降(1.46±2.09)、(1.25±1.82)、(2.49±3.64)D(t=3.12、3.06、3.50;P=0.006、0.006、0.007)。
- 术后两组RGPCL矫正视力、屈光度数及直径均无改变,但RGPCL基弧均减小,去上皮组减小0.07 mm,经上皮组减小0.13 mm(P均<0.05)。
- 去上皮组术后抬边翘设计10只眼,较术前8只眼增加;经上皮组术后4只眼,较术前7只眼减少。环曲面边翘设计去上皮组术前2只眼增至术后3只眼,经上皮组术前1只眼增至术后4只眼。两组术后6及12个月RGPCL配适可接受率均较术后6周增加。
关键数值与推荐
- 去上皮组术后12个月Kmax下降(0.89±1.45)D(t=2.25,P=0.001)。
- 经上皮组术后3、6、12个月Kmax分别下降(1.46±2.09)、(1.25±1.82)、(2.49±3.64)D(P=0.006、0.006、0.007)。
- RGPCL基弧去上皮组减小0.07 mm,经上皮组减小0.13 mm(P均<0.05)。
临床怎么用
- 圆锥角膜患眼行CXL术后6周角膜略变凸后逐渐恢复并变平,经上皮术式效果更好。
- 术后6周配适RGPCL时基弧应较术前变陡,并考虑环曲面边翘设计需求增加。
- RGPCL于CXL术后1年内仍可良好配适。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect of corneal collagen cross-linking (CXL) for progressive keratoconus and to evaluate changes in the parameters of rigid gas permeable contact lens (RGPCL) fitting after surgery. Methods: It was a prospective cohort study. Fifty-three eyes of 41 keratoconus patients received accelerated CXL in Qingdao Eye Hospital of Shandong First Medical University from May to December 2018. There were 31 males and 10 females, aged (20.46±4.15) years. According to the corneal thickness, de-epithelial CXL (33 eyes) or trans-epithelial CXL (20 eyes) was performed. The best spectacle-corrected visual acuity, refractive power and the thinnest corneal thickness at baseline and at 6 weeks were compared. Corneal topography was performed at baseline and at 6 weeks, 3, 6 and 12 months postoperatively. Rose K RGPCLs were used before and 6 weeks after surgery, and the fitting status was monitored until 12 months after surgery. The t test was performed to analyze the difference before and after the operation. Results: The best spectacle-corrected visual acuity, refractive power, and the thinnest corneal thickness were not significantly changed over 6 weeks of follow-up, but the Kf, Ks and Kmax values were significantly increased in all patients (all P<0.05). In the de-epithelial group, the Kmax values before the operation, at 3, 6 and 12 months after the operation were (55.00±5.51) diopters (D), (54.73±5.34) D, (54.58±6.15) D and (54.20±5.49) D, respectively, and the decrease at 12 months was significant [(0.80±2.05) D; t=2.25, P=0.001]. In the trans-epithelial group, the Kmax values were (59.43±8.98) D, (57.97±8.79) D, (58.19±8.37) D and (56.94±7.19) D at the four time points, respectively, and the decreases at 3, 6 and 12 months were all significant [(1.46±2.09) D, (1.25±1.82) D, (2.49±3.64) D; t=3.12, 3.06, 3.50; P=0.006, 0.006, 0.007]. The best RGPCL-corrected visual acuity, the diameter and the average diopters of RGPCLs showed no significant change in both groups. The RGPCL base curve decreased by 0.07 mm in the de-epithelial group and by 0.13 mm in the trans-epithelial group (both P<0.05). The design of edge lifting was used in 10 eyes postoperatively in the de-epithelial group compared with 8 eyes preoperatively, and in 4 eyes postopratively in the trans-epithelial group compared with 7 eyes preoperatively. The number of eyes using the toric peripheral design of the lens was increased to 3 compared with 2 preoperatively in the de-epithelial group and from 1 to 4 in the trans-epithelial group. The acceptance rate of RGPCL fitting in both groups increased at 6 and 12 months after surgery compared to 6 weeks after surgery. Conclusions: The corneal curvature became steep slightly at 6 weeks after CXL and gradually recovered and flattened. The Kmax in the trans-epithelial group decreased earlier and more than that in the de-epithelial group. The base curve of the RGPCLs was slightly reduced after 6 weeks, and the toric peripheral design was increasingly needed, but the requirement for the design of the lifted edge was different between the two groups. A good RGPCL fitting can be achieved within 1 year after CXL. 目的: 探讨圆锥角膜患眼行角膜胶原交联术(CXL)后1年的治疗效果及术后硬性透气性角膜接触镜(RGPCL)适配参数的改变。 方法: 前瞻性队列研究。纳入自2018年5至12月于山东第一医科大学附属青岛眼科医院门诊接受快速CXL的进展期圆锥角膜患者41例(53只眼),其中男性31例,女性10例,年龄(20.46±4.15)岁。根据角膜最薄点厚度是否≥450 μm分为去上皮组(33只眼)和经上皮组(20只眼),分别采用去上皮术式和经上皮术式行CXL。术前及术后6周适配RGPCL并追踪配适情况至术后12个月。所有患眼术前和术后6周检查最佳矫正视力和角膜最薄点厚度,术前、术后6周和3、6、12个月进行角膜地形图检查获取平坦角膜曲率(Kf)、陡峭角膜曲率(Ks)及最大角膜曲率(Kmax)。采用t检验对数据进行统计学分析。 结果: 术后6周时两组框架镜矫正视力、屈光度数及角膜最薄点厚度较术前无改变,但Kf、Ks及Kmax均增加(P均<0.05);至术后3个月两组Kmax呈现下降趋势,其中去上皮术组术前及术后3、6、12个月的Kmax分别为(55.46±6.02)、(55.17±5.83)、(55.14±6.15)、(54.57±6.08)D,其中术后12个月下降显著,为(0.89±1.45)D(t=2.25,P=0.001);经上皮组术前及术后3、6、12个月的Kmax分别为(59.43±8.98)、(57.97±8.79)、(58.19±8.37)、(56.94±7.19)D,术后3、6及12个月均下降显著,且降幅更大,分别为(1.46±2.09)、(1.25±1.82)、(2.49±3.64)D(t=3.12,3.06,3.50;P=0.006,0.006,0.007)。术后两组RGPCL矫正视力、屈光度数及直径均无改变,但RGPCL基弧均减小,去上皮组减小0.07 mm而经上皮组减小0.13 mm(P均<0.05);另外,去上皮组术后抬边翘设计10只眼,较术前8只眼增加,而经上皮组术前(7只眼)较术后(4只眼)减少。环曲面边翘设计眼两组均较术前增多,去上皮组术前为2只眼,术后增加至3只眼,经上皮组术前为1只眼,术后增加至4只眼。两组术后6及12个月时RGPCL配适可接受率均较术后6周增加。 结论: 圆锥角膜患眼行CXL术后6周,角膜略变凸后逐渐恢复并变平,经上皮术式效果更好;术后6周配适RGPCL的基弧较术前变陡,边翘环曲面设计需求增加,但抬边翘设计两种术式变化不同;RGPCL于术后1年仍可良好配适。.
引用
- Zhao CP, Ji RY, Han YM, et al. [The mid-term effect of corneal collagen cross-linking for progressive keratoconus and the changes in rigid gas permeable contact lens fitting parameters]. Zhonghua Yan Ke Za Zhi. 2022. PMID: 35391514. doi:10.3760/cma.j.cn112142-20220129-00029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。